Introduction {#s1}
============

Aging is associated with a decline in cardiac function in humans as well as rodents (Lakatta and Sollott, [@B28]). The decline in cardiac function with age is associated with changes in mitochondrial function and energy metabolism (Abu-Erreish et al., [@B1]; McMillin et al., [@B32]; Fannin et al., [@B12]; Kates et al., [@B25]; Bhashyam et al., [@B5]; Chakravarti et al., [@B8]). Since the myocardium derives nearly all of its energetic needs from the oxidation of pyruvate and fatty acids within the mitochondria, mitochondrial changes have great potential to contribute to cardiac dysfunction with age. Indeed, mitochondrial energetic deficiency with aging has been well-documented (McMillin et al., [@B32]; Fannin et al., [@B12]; Phaneuf and Leeuwenburgh, [@B41]; Chakravarti et al., [@B8]; Ventura-Clapier et al., [@B54]). The mechanisms of this mitochondrial dysfunction may include biogenesis that is inadequate to match the increasing demand (Goffart et al., [@B14]), as well as increased mitochondrial uncoupling and decreased substrate availability (Murray et al., [@B35]). Several studies have documented age-dependent impairment in the mitochondrial respiratory capacity (Kumaran et al., [@B26]; Navarro and Boveris, [@B36]).

Concomitant with mitochondria functional changes there is a change in cardiac substrate utilization during the aging process. At rest, fatty acids are the primary substrate for ATP supply in the myocardium and glucose uptake and oxidation supplies the remainder of the carbon substrates (Wisneski et al., [@B57]). There is some evidence that this substrate utilization changes with age (Abu-Erreish et al., [@B1]; McMillin et al., [@B32]; Sample et al., [@B46]), with most evidence indicating an age-related reduction in fatty acid oxidation, with the implication of increased reliance on glucose, although this is not universally seen (Sample et al., [@B46]). Interestingly, it has been determined that glucose utilization itself does not increase (Abu-Erreish et al., [@B1]; McMillin et al., [@B32]; Kates et al., [@B25]).

The molecular mechanisms underlying age-related changes in mitochondrial function or substrate energy metabolism is largely unknown. Decreases in mRNA levels of peroxisome proliferator-activated receptor (PPARα), and some of its downstream targets (i.e., CPT-1, β-hydroxyacyl dehydrogenase) have been observed with age (Iemitsu et al., [@B22]). In addition, peroxisome proliferator activated receptor γ coactivator-1α (PGC-1α) protein content is reduced in the aging left ventricle (Turdi et al., [@B53]). PPARα is a transcription factor for genes involved with fatty acid transport and β-oxidation (Huss and Kelly, [@B20]). PGC-1α, a co-transcription factor is known to stimulate mitochondrial DNA replication and the coding for genes involved with oxidative phosphorylation (Huss and Kelly, [@B20]). Another mechanism for age-related changes in substrate metabolism may be related to AMP-activated protein kinase (AMPK) activity. Dually activated by AMP and by upstream phosphorylation, this kinase promotes fatty acid oxidation, glucose uptake, and glycogenolysis while it inhibits anabolic processes such as fatty acid synthesis (Munday et al., [@B33]; Coven et al., [@B9]; Hawley et al., [@B18], [@B19]; Scott et al., [@B47]). There is evidence that AMPK activity declines with age (Gonzalez et al., [@B15]; Turdi et al., [@B53]). Changes in the expression, protein content, or activity of PPARα, PGC-1α, and AMPK can help explain some of the known changes in substrate metabolism and mitochondrial function with age. However, these processes are the result of complex pathways that require the coordinated expression and function of a large number of genes and proteins, but there are few studies that have examined the effects of aging on the expression of the comprehensive array of genes that are associated with substrate metabolism and mitochondrial function.

Exercise training is known to improve indices of cardiac function in humans (Fortney et al., [@B13]; Seals et al., [@B48]) and rodents (Spurgeon et al., [@B51]; Iemitsu et al., [@B22]). Specifically, these functional improvements include, increased contractile function (Spurgeon et al., [@B51]; Fortney et al., [@B13]; Seals et al., [@B48]; Iemitsu et al., [@B22]) and increased maximal oxygen uptake (VO~2max~) (Ogawa et al., [@B38]; Seals et al., [@B48]; Stratton et al., [@B52]). There is some evidence that exercise can alter the metabolic phenotype of the aging heart. Exercise training in aging Wistar rats increased AMPK activity, PPARα mRNA and protein content, and proteins involved in fatty acid oxidation in the young and aged heart (Iemitsu et al., [@B22]; Rimbaud et al., [@B44]; Dobrzyn et al., [@B10]). Also, lifelong voluntary wheel running in mice increased electron transport chain (ETC) complex IV gene expression (Bronikowski et al., [@B6]). There is molecular evidence that exercise training can increase the mRNA and protein levels of important proteins involved with fatty acid oxidation and oxidative phosphorylation, these markers suggest that these metabolic pathways may be improved with exercise training (Iemitsu et al., [@B22]; Bronikowski et al., [@B6]; Rimbaud et al., [@B44]; Dobrzyn et al., [@B10]). However, substrate metabolism and mitochondrial oxidative phosphorylation in the heart are regulated by the transcription, translation, and activity of many genes in order to optimally function.

Therefore, the aims of this study was to: (1) determine the effects of age on the expression of a large number of genes related to the pathways of glucose and fatty acid metabolism, and mitochondrial function; and (2) determine whether exercise training could mitigate age-related changes in the expression of metabolic and mitochondrial genes in the aging rat heart. We hypothesize that expression of genes associated with the pathways of fatty acid metabolism, AMPK signaling, and mitochondrial function will decrease with age and that the addition of exercise training in these aged rats will mitigate this decrease in gene expression.

Materials and methods {#s2}
=====================

Animals
-------

Male Fischer 344 x Brown Norway hybrid rats (FBN), were obtained from the National Institute on Aging colony at Harlan Industries (Indianapolis, IN). The FBN hybrid rat is a long-lived strain with a median life-span of 33 months and a maximum life-span of 40 months. The FBN rat is considered a "healthy aging model" widely used and highly recommended for gerontological research. All rats were confined to standard size rodent cages and housed 2 rats per cage. Rats had access to food and water *ad libitum* and were acclimated to reverse daylight (12 h dark, 12 h light). Body weights and average food intake were monitored through the course of the study. Rats were randomly assigned to one of three groups: Young (6 month), Old (33--34 month), and Old + Exercise (Old+EXE) (33--34 month). Animal housing and handling was carried out under the guidelines of the University of Wisconsin-Madison Institutional Animal Care and Use Committees and conducted in pathogen-free facilities that are accredited by the American Association of Accreditation of Laboratory Animal Care.

Tissue collection
-----------------

Old and Old + EXE hearts were removed and flash frozen in liquid nitrogen 72 h from the last maximal exercise test in order to control for transient gene expression changes due to acute exercise (Neufer and Dohm, [@B37]; Pilegaard et al., [@B42]). From the Old (*n* = 9) and Old + EXE (*n* = 9) rats, 5 hearts were randomly selected for qRT-PCR, Western blot, and citrate synthase experiments, while Young (*n* = 5) hearts were used for molecular analysis.

Maximal exercise testing
------------------------

Assessment of peak exercise capacity occurred each month beginning at 30 months until 34 months of age. The exercise test started with a treadmill speed at 5 m/min and progressively increased by 3 m/min at each exercise stage. Animals ran at each new treadmill speed for 3 min to assure steady-state values. To encourage the rats to run, the treadmill was equipped with an electric shock grid at the rear of the treadmill. The shock grid was set to deliver a 0.2 mA current, which gives an uncomfortable shock but does not physically harm or injure the rat. The test was terminated when animals were no longer able to maintain position on the treadmill, and the highest speed was recorded as peak exercise capacity. Blood lactate levels were measured during the graded exercise tests. Blood lactate levels were used to quantify relative exercise intensity. At the end of each 3 min interval, animals were briefly removed from the treadmill, immobilized with the tail extended, the lateral tail vein pierced, and a drop (\~25 μL) of blood was collected on a lactate strip inserted into a lactate meter (Lactate Plus Meter, Nova Biomedical). Blood lactate values were recorded at each exercise intensity level during the exercise test.

Training protocol
-----------------

Trained animals were exercised on a motor driven treadmill during their 12 h dark cycle. Before training began, animals were treadmill acclimatized for 2 weeks at 5 m/min for 5 min during the first week and at 5 m/min for 10 min the second week. After acclimatization, maximal exercise tests were performed and blood lactate measurements were taken at each successive speed on the treadmill during the test. The endurance trained rats began exercise training at 30 months of age with a training program that following 2 weeks of treadmill acclimation consisted of 30 min/day, 5 days per week at a speed that corresponded to each animal\'s lactate threshold. Thus, the training speed was adjusted each month based on the results of the maximal exercise tests (above). All exercise training sessions included a 3 min warm-up period at 5 m/min. No negative stimuli (electric shock) were used during the daily exercise training of the animals to minimize stress involved in exercise for these aging animals.

RNA isolation and cDNA preparation
----------------------------------

Rats were terminated using isoflurane/pneumothorax euthanasia and hearts were removed and flash frozen in liquid nitrogen. Total RNA from each rat was isolated from the left ventricular free wall using RNeasy® Microarray Tissue Mini Kit (Qiagen) according to the manufacturer instruction. Immediately after elution RNA concentration and purity was measured spectrophotometrically (Beckman-Coulter). For each sample 700 ng of total RNA was reversed transcribed using the RT^2^ First Strand Kit (Qiagen). The reaction was performed at 42°C for 15 min followed by a termination step at 95°C for 5 min. cDNA was stored at −20°C until qRT-PCR.

qRT-PCR data analysis
---------------------

A total of 251 genes of interest across three PCR arrays from Qiagen were assayed for this study (Glucose Metabolism RT^2^ Profiler PCR Array, Fatty Acid Metabolism RT^2^ Profiler PCR Array and RT^2^ Custom PCR Array for mitochondrial function). A list of all of the genes contained in each array can be found in Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}. PCR was performed on Step-One Plus PCR system (Applied Biosystems), according to the manufacturer\'s instructions. For data analysis, the ΔΔCt method was used with the aid of a Microsoft Excel spreadsheet containing algorithms and a student\'s *t*-test was used to analyze differences in fold-changes in gene expression provided by the manufacturer (Hassmann-Poznańska et al., [@B17]; Wu et al., [@B58]; Okada et al., [@B39]). The ΔΔCt method for calculating differences in gene expression are as follows: (ΔCt = Ct^GOI^ − Ct^AVG\ HKG^, where GOI is the gene of interest and HKG is the housekeeping gene selected. ΔΔCt = (ΔCt (Experimental group) −ΔCt (Control)). The housekeeping gene selected for data analysis was Ribosomal protein, large P1 (Rplp1). Fold-changes were then calculated and expressed as log-normalized ratios of values from Old/Young, Old + EXE/Young and Old + EXE/Old heart tissues.

###### 

**Gene list Glucose metabolism array**.

  **Symbol**   **Description**
  ------------ ----------------------------------------------------------------------------------
  Acly         ATP citrate lyase
  Aco1         Aconitase 1, soluble
  Aco2         Aconitase 2, mitochondrial
  Agl          Amylo-1,6-glucosidase, 4-alpha-glucanotransferase
  Aldoa        Aldolase A, fructose-bisphosphate
  Aldob        Aldolase B, fructose-bisphosphate
  Aldoc        Aldolase C, fructose-bisphosphate
  Bpgm         2,3-bisphosphoglycerate mutase
  Cs           Citrate synthase
  Dlat         Dihydrolipoamide S-acetyltransferase
  Dld          Dihydrolipoamide dehydrogenase
  Dlst         Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
  Eno1         Enolase 1, (alpha)
  Eno2         Enolase 2, gamma, neuronal
  Eno3         Enolase 3, beta, muscle
  Fbp1         Fructose-1,6-bisphosphatase 1
  Fbp2         Fructose-1,6-bisphosphatase 2
  Fh           Fumarate hydratase 1
  G6pc         Glucose-6-phosphatase, catalytic subunit
  G6pc3        Glucose 6 phosphatase, catalytic, 3
  G6pd         Glucose-6-phosphate dehydrogenase
  Galm         Galactose mutarotase (aldose 1-epimerase)
  Gapdh        Glyceraldehyde-3-phosphate dehydrogenase
  Gapdhs       Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
  Gck          Glucokinase
  Gpi          Glucose phosphate isomerase
  Gsk3a        Glycogen synthase kinase 3 alpha
  Gsk3b        Glycogen synthase kinase 3 beta
  Gys1         Glycogen synthase 1, muscle
  Gys2         Glycogen synthase 2
  H6pd         Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
  Hk2          Hexokinase 2
  Hk3          Hexokinase 3 (white cell)
  Idh1         Isocitrate dehydrogenase 1 (NADP+), soluble
  Idh2         Isocitrate dehydrogenase 2 (NADP+), mitochondrial
  Idh3a        Isocitrate dehydrogenase 3 (NAD+) alpha
  Idh3b        Isocitrate dehydrogenase 3 (NAD+) beta
  Idh3g        Isocitrate dehydrogenase 3 (NAD), gamma
  Mdh1         Malate dehydrogenase 1, NAD (soluble)
  Mdh1b        Malate dehydrogenase 1B, NAD (soluble)
  Mdh2         Malate dehydrogenase 2, NAD (mitochondrial)
  Ogdhl        Oxoglutarate dehydrogenase-like
  Pc           Pyruvate carboxylase
  Pck1         Phosphoenolpyruvate carboxykinase 1 (soluble)
  Pck2         Phosphoenolpyruvate carboxykinase 2 (mitochondrial)
  Pdha2        Pyruvate dehydrogenase (lipoamide) alpha 2
  Pdhb         Pyruvate dehydrogenase (lipoamide) beta
  Pdhx         Pyruvate dehydrogenase complex, component X
  Pdk1         Pyruvate dehydrogenase kinase, isozyme 1
  Pdk2         Pyruvate dehydrogenase kinase, isozyme 2
  Pdk3         Pyruvate dehydrogenase kinase, isozyme 3
  Pdk4         Pyruvate dehydrogenase kinase, isozyme 4
  Pdp2         Pyruvate dehyrogenase phosphatase catalytic subunit 2
  Pdpr         Pyruvate dehydrogenase phosphatase regulatory subunit
  Pfkl         Phosphofructokinase, liver
  Pgam2        Phosphoglycerate mutase 2 (muscle)
  Pgk1         Phosphoglycerate kinase 1
  Pgk2         Phosphoglycerate kinase 2
  Pgls         6-phosphogluconolactonase
  Pgm1         Phosphoglucomutase 1
  Pgm2         Phosphoglucomutase 2
  Pgm3         Phosphoglucomutase 3
  Phka1        Phosphorylase kinase, alpha 1
  Phkb         Phosphorylase kinase, beta
  Phkg1        Phosphorylase kinase, gamma 1
  Phkg2        Phosphorylase kinase, gamma 2 (testis)
  Pklr         Pyruvate kinase, liver, and RBC
  Prps1        Phosphoribosyl pyrophosphate synthetase 1
  Prps1l1      Phosphoribosyl pyrophosphate synthetase 1-like 1
  Pygl         Phosphorylase, glycogen, liver
  Pygm         Phosphorylase, glycogen, muscle
  Rbks         Ribokinase
  Rpia         Ribose 5-phosphate isomerase A
  Sdha         Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
  Sdhb         Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
  Sdhc         Succinate dehydrogenase complex, subunit C, integral membrane protein
  Sdhd         Succinate dehydrogenase complex, subunit D, integral membrane protein
  Sucla2       Succinate-CoA ligase, ADP-forming, beta subunit
  Suclg1       Succinate-CoA ligase, alpha subunit
  Suclg2       Succinate-CoA ligase, GDP-forming, beta subunit
  Taldo1       Transaldolase 1
  Tkt          Transketolase
  Tpi1         Triosephosphate isomerase 1
  Ugp2         UDP-glucose pyrophosphorylase 2

###### 

**Gene list for Fatty Acid metabolism array**.

  **Symbol**   **Description**
  ------------ ----------------------------------------------------------------------
  Acaa1a       Acetyl-Coenzyme A acyltransferase 1A
  Acaa2        Acetyl-Coenzyme A acyltransferase 2
  Acad10       Acyl-Coenzyme A dehydrogenase family, member 10
  Acad11       Acyl-Coenzyme A dehydrogenase family, member 11
  Acad9        Acyl-Coenzyme A dehydrogenase family, member 9
  Acadl        Acyl-Coenzyme A dehydrogenase, long-chain
  Acadm        Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain
  Acads        Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain
  Acadsb       Acyl-Coenzyme A dehydrogenase, short/branched chain
  Acadvl       Acyl-Coenzyme A dehydrogenase, very long chain
  Acat1        Acetyl-coenzyme A acetyltransferase 1
  Acat2        Acetyl-Coenzyme A acetyltransferase 3
  Acot12       Acyl-CoA thioesterase 12
  Acot2        Acyl-CoA thioesterase 2
  Acot3        Acyl-CoA thioesterase 3
  Acot7        Acyl-CoA thioesterase 7
  Acot8        Acyl-CoA thioesterase 8
  Acot9        Acyl-CoA thioesterase 9
  Acox1        Acyl-Coenzyme A oxidase 1, palmitoyl
  Acox2        Acyl-Coenzyme A oxidase 2, branched chain
  Acox3        Acyl-Coenzyme A oxidase 3, pristanoyl
  Acsbg1       Acyl-CoA synthetase bubblegum family member 1
  Acsbg2       Acyl-CoA synthetase bubblegum family member 2
  Acsl1        Acyl-CoA synthetase long-chain family member 1
  Acsl3        Acyl-CoA synthetase long-chain family member 3
  Acsl4        Acyl-CoA synthetase long-chain family member 4
  Acsl5        Acyl-CoA synthetase long-chain family member 5
  Acsl6        Acyl-CoA synthetase long-chain family member 6
  Acsm2a       Acyl-CoA synthetase medium-chain family member 2
  Acsm3        Acyl-CoA synthetase medium-chain family member 3
  Acsm4        Acyl-CoA synthetase medium-chain family member 4
  Acsm5        Acyl-CoA synthetase medium-chain family member 5
  Aldh2        Aldehyde dehydrogenase 2 family (mitochondrial)
  Bdh1         3-hydroxybutyrate dehydrogenase, type 1
  Bdh2         3-hydroxybutyrate dehydrogenase, type 2
  Cpt1a        Carnitine palmitoyltransferase 1a, liver
  Cpt1b        Carnitine palmitoyltransferase 1b, muscle
  Cpt1c        Carnitine palmitoyltransferase 1c
  Cpt2         Carnitine palmitoyltransferase 2
  Crat         Carnitine acetyltransferase
  Crot         Carnitine O-octanoyltransferase
  Decr1        2,4-dienoyl CoA reductase 1, mitochondrial
  Decr2        2,4-dienoyl CoA reductase 2, peroxisomal
  Echs1        Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
  Eci2         Enoyl-Coenzyme A delta isomerase 2
  Ehhadh       Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase
  Fabp1        Fatty acid binding protein 1, liver
  Fabp2        Fatty acid binding protein 2, intestinal
  Fabp3        Fatty acid binding protein 3, muscle, and heart
  Fabp4        Fatty acid binding protein 4, adipocyte
  Fabp5        Fatty acid binding protein 5, epidermal
  Fabp6        Fatty acid binding protein 6, ileal
  Fabp7        Fatty acid binding protein 7, brain
  Gcdh         Glutaryl-Coenzyme A dehydrogenase
  Gk           Glycerol kinase
  Gk2          Glycerol kinase 2
  Gpd1         Glycerol-3-phosphate dehydrogenase 1 (soluble)
  Gpd2         Glycerol-3-phosphate dehydrogenase 2, mitochondrial
  Hadha        Hydroxyacyl-Coenzyme A dehydrogenase[^a^](#TN1){ref-type="table-fn"}
  Hmgcl        3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase
  Hmgcs1       3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)
  Hmgcs2       3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial)
  Lipe         Lipase, hormone sensitive
  Lpl          Lipoprotein lipase
  Mcee         Methylmalonyl CoA epimerase
  Mut          Methylmalonyl-Coenzyme A mutase
  Oxct2a       3-oxoacid CoA transferase 2A
  Pecr         Peroxisomal trans-2-enoyl-CoA reductase
  Ppa1         Pyrophosphatase (inorganic) 1
  Prkaa1       Protein kinase, AMP-activated, alpha 1 catalytic subunit
  Prkaa2       Protein kinase, AMP-activated, alpha 2 catalytic subunit
  Prkab1       Protein kinase, AMP-activated, beta 1 non-catalytic subunit
  Prkab2       Protein kinase, AMP-activated, beta 2 non-catalytic subunit
  Prkaca       Protein kinase, cAMP-dependent, catalytic, alpha
  Prkacb       Protein kinase, cAMP dependent, catalytic, beta
  Prkag1       Protein kinase, AMP-activated, gamma 1 non-catalytic subunit
  Prkag2       Protein kinase, AMP-activated, gamma 2 non-catalytic subunit
  Prkag3       Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
  Slc27a1      Solute carrier family 27 (fatty acid transporter), member 1
  Slc27a2      Solute carrier family 27 (fatty acid transporter), member 2
  Slc27a3      Solute carrier family 27 (fatty acid transporter), member 3
  Slc27a4      Solute carrier family 27 (fatty acid transporter), member 4
  Slc27a5      Solute carrier family 27 (fatty acid transporter), member 5
  Slc27a6      Solute carrier family 27 (fatty acid transporter), member 6

Hydroxyacyl-Coenzyme A dehydrogenase 3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit.

###### 

**Gene list for the Custom array**.

  **Symbol**   **Description**
  ------------ ------------------------------------------------------------------------
  Ppargc1      Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  Nrf1         Nuclear respiratory factor 1
  Tfam         Transcription factor A, mitochondrial
  Sir2         Sirtuin (Silent mating type information regulation 2 homolog) 2
  Esrra        Estrogen related receptor, alpha
  Prkaa2       Protein kinase, AMP-activated, alpha 2 catalytic subunit
  CREB1        cAMP response element binding protein 1
  CaMK4        Calcium/calmodulin-dependent protein kinase IV
  SOD2         Superoxide dismutase 2, mitochondrial
  UCP2         Uncoupling protein 2 (mitochondrial proton carrier)
  UCP3         Uncoupling protein 3 (mitochondrial proton carrier)
  Bax          Bcl2--associated X protein
  Bcl2         B-cell CLL/lymphoma 2
  Casp3        Caspase 3
  Gabpa        GA binding protein transcription factor (alpha subunit) (i.e., NRF-2a)
  UCP1         Uncoupling protein 1 (mitochondrial proton carrier)
  Ppara        Peroxisome proliferator activated receptor alpha
  Slc2a4       Solute carrier family 2 (facilitated glucose transporter) member 4
  CD36         CD 36 molecule (thrombospondin receptor)
  Acacb        Acetyl-Coenzyme A carboxylase beta
  Mlycd        Malonyl-CoA decarboxylase
  Ndufa1       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1
  Ndufa10      NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10
  Ndufa11      NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11
  Ndufa2       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2
  Ndufa5       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5
  Ndufa6       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6
  Ndufa7       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7
  Ndufa8       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8
  Ndufa9       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
  Ndufab1      NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex, 1
  Ndufb2       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2
  Ndufb3       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3
  Ndufb5       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5
  Ndufb6       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6
  Ndufb7       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
  Ndufb8       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8
  Ndufb9       NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9
  Ndufc2       NADH dehydrogenase (ubiquinone) 1 subcomplex unknown, 2
  Ndufs1       NADH dehyrogenase (ubiquinone) Fe-S protein 1
  Ndufs2       NADH dehyrogenase (ubiquinone) Fe-S protein 2
  Ndufs3       NADH dehyrogenase (ubiquinone) Fe-S protein 3
  Ndufs4       NADH dehyrogenase (ubiquinone) Fe-S protein 4
  Ndufs6       NADH dehyrogenase (ubiquinone) Fe-S protein 6
  Ndufs7       NADH dehyrogenase (ubiquinone) Fe-S protein 7
  Ndufs8       NADH dehyrogenase (ubiquinone) Fe-S protein 8
  Ndufv1       NADH dehydrogenase (ubiquinone) flavoprotein 1
  Ndufv2       NADH dehyrogenase (ubiquinone) flavoprotein 2
  Bcs1l        BCS1-like yeast
  Cyc1         Cytochrome c-1
  Uqcrb        Ubiquinol-cytochrome c reductase binding protein
  Uqcrc1       Ubiquinol-cytochrome c reductase core protein 1
  Uqcrc2       Ubiquinol-cytochrome c reductase core protein 2
  Uqcrfs1      Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
  Uqcrh        Ubiquinol-cytochrome c reductase hinge protein
  Uqcrq        Ubiquinol-cytochrome c reductase, complex III subunit VII
  Cox15        COX 15 homolog, cytochrome c oxidase assembly protein (yeast)
  Cox17        COX 17 cytochrome c oxidase assembly homolog (*S. cerevisiae*)
  Cox4i1       Cytochrome c oxidase subunit IV isoform 1
  Cox4i2       Cytochrome c oxidase subunit IV isoform 2
  Cox5a        Cytochrome c oxidase subunit Va
  Cox5b        Cytochrome c oxidase subunit Vb
  Cox6a1       Cytochrome c oxidase subunit VIa polypeptide 1
  Cox6a2       Cytochrome c oxidase subunit VIa polypeptide 2
  Cox6c        Cytochrome c oxidase subunit VIc
  Cox7a2       Cytochrome c oxidase subunit VIIa polypeptide 2
  Cox7a2l      Cytochrome c oxidase subunit VIIa polypeptide 2 like
  Cox7b        Cytochrome c oxidase subunit VIIb polypeptide
  Cox8a        Cytochrome c oxidase subunit VIIIa
  Cox8c        Cytochrome c oxidase subunit VIIIc
  mfn1         Mitofusin 1
  mfn2         Mitofusin 2
  fis1         Fission 1 (mitochondrial outer membrane) homolog (*S. cerevisiae*)
  lonp1        Lon protease
  Aifm2        Apoptosis-inducing factor, mitochondrial-associated 2
  Bcl2l1       Bcl2-like 1
  Clpb         ClpB caseinolytic peptidase B homolog (*E. coli*) (i.e. HSP 78)
  pnpt1        Polyribonucleotide nucleotidyltransferase 1
  Me1          Malic enzyme 1, NADP(+)-dependent, cytosolic
  Foxo3        Forkhead box O3
  Camkk2       Calcium/calmodulin-dependent protein kinase kinase 2,beta
  Stk11        Serine/threonine kinase 11 (i.e., LKB1)
  Ppargc1b     Peroxisome proliferator-activated receptor gamma, coactivator 1 beta
  Tp53         Tumor protein p53

Western blotting
----------------

Whole cell lysate from isolated left ventricle was prepared using CelLytic™ MT Cell Lysis Reagent and 1:100 dilution of Protease Inhibitor Cocktail (Sigma, St. Louis, MO). The protein concentration was determined using Bio-Rad Protein Assay (BioRad, Hercules, CA). Thirty micrograms of whole cellular protein per lane was separated by SDS-PAGE with a 4--12% Bis-Tris Criterion™ XT gel (XT MOPS running buffer) and blotted onto a nitrocellulose membrane. The membrane was incubated with blocking buffer (5% non-fat dry milk/TBS/0.1% Tween 20) at room temperature for 1 h. The membrane was then probed with the primary antibodies diluted in blocking buffer overnight at 4°C. Subsequently, membranes were incubated with horseradish peroxidase-conjugated anti-rabbit antibody diluted 1:2000 in blocking buffer. Blots were developed with Clarity™ Western ECL substrate (BioRad, Hercules, CA) and imaged with GE ImageQuant LAS-4000 (GE Healthcare Bio-Sciences, Pittsburgh, PA). The image of the blots was uploaded and densitometry analysis was done with Image Studio Lite (LI-COR Biosciences, Lincoln, NE). Protein content was measured from the densitometry units from PGC-1α, AMPKα~2~,PPARα, and normalized to vinculin.

Antibodies
----------

Rabbit anti-PGC-1α, AMPKα~2~, and Vinculin antibodies were acquired from Cell Signaling Technology, Inc., Beverly, MA. Rabbit anti-PPARα antibody was purchased from Santa Cruz Biotechnology, Inc., Santa Cruz, CA.

Citrate synthase activity
-------------------------

Maximal citrate synthase (CS) activity was determined in left ventricular homogenates using (Citrate Synthase Assay Kit, Sigma-Aldrich, St Louis, MO, USA) according to the manufacturer\'s protocol with absorbance kinetically measured at 412 nm at baseline and after addition of oxaloacetate (Sigma-Aldrich). CS activity was normalized to protein content with tissue protein determined using the Bio-Rad protein assay.

Statistical analysis
--------------------

A two-tailed Student\'s *t*-test was used for analyzing differences in gene expression and exercise performance. A one-way ANOVA was utilized to analyze differences in protein content and citrate synthase activity. *Post-hoc* analysis was performed when the one-way ANOVA was significant using Tukey\'s LSD to assess between group differences. Significance was determined at *p* \< 0.05.

Results {#s3}
=======

Effects of exercise training on exercise performance
----------------------------------------------------

The effect of 4 months of exercise training on exercise performance in 34 month old trained (Old + EXE) FBN rats compared to sedentary (Old SED) rats was significant (Figure [1](#F1){ref-type="fig"}). We measured exercise capacity in two different ways; (1) treadmill speed at lactate threshold (LT) and (2) peak exercise capacity (the final treadmill speed achieved during the maximal exercise test). Exercise training significantly improved lactate threshold (*p* \< 0.01) in the Old + EXE rats compared to Old SED rats (Figure [1A](#F1){ref-type="fig"}). Peak exercise capacity was also greater (*p* = 0.01) in the Old + EXE rats compared to Old SED rats (Figure [1B](#F1){ref-type="fig"}).

![**Effects of exercise training on peak exercise capacity in 34 month old FBN rats**. Values are the Means ± S.E.M of treadmill speed and peak exercise capacity of trained and sedentary rats. **(A)** We measured exercise capacity as a function of treadmill speed at lactate threshold (LT) **(B)** Peak exercise capacity was measured as the maximal speed at the end of the maximal exercise testing. Old SED (*n* = 9), Old + EXE (*n* = 9). ^\*^*P* \< 0.05.](fphys-07-00352-g0001){#F1}

Gene expression changes with age
--------------------------------

To determine the effects of age on the expression of genes involved in cardiac glucose and fatty acid metabolism as well as mitochondrial function we performed qRT-PCR using three different PCR arrays. Table [4](#T4){ref-type="table"} shows all genes in the energetic pathways for which expression was significantly different between Old and Young rats. Between the three arrays there were a total of 44 genes that were differentially expressed (*p* \< 0.05) in Old compared to Young. Of the 44 genes differentially expressed, 42 of these genes had decreased expression in Old compared to Young. Notably, the expression profile of three important pathways of energy production were altered with age; fatty acid oxidation (FAO), mitochondrial biogenesis, and AMPK signaling. There were no significant changes in glucose metabolism gene expression with age. Figure [2](#F2){ref-type="fig"} shows changes in expression with age in key genes involved in the pathways of FAO, mitochondrial biogenesis, and AMPK signaling.

###### 

**Age-related gene expression changes in the left ventricle**.

  **Gene name**                                                                                                                           **Gene symbol**   **Fold Regulation**   ***p*-value**
  --------------------------------------------------------------------------------------------------------------------------------------- ----------------- --------------------- ---------------
  **FA METABOLISM**                                                                                                                                                               
  Acyl-CoA thioesterase 12                                                                                                                Acot12            2.88                  0.026
  Acyl-CoA thioesterase 7                                                                                                                 Acot7             --1.86                0.017
  Acyl-CoA thioesterase 8                                                                                                                 Acot8             --1.44                0.02
  Acyl-Coenzyme A oxidase 1, palmitoyl                                                                                                    Acox1             --2.1                 0.032
  Acyl-CoA synthetase bubblegum family member 1                                                                                           Acsbg1            2.09                  0.034
  Acyl-CoA synthetase long-chain family member 6                                                                                          Acsl6             --1.98                0.029
  3-hydroxybutyrate dehydrogenase, type 1                                                                                                 Bdh1              --2.55                0.036
  Carnitine palmitoyltransferase 1c                                                                                                       Cpt1c             --1.49                0.027
  Carnitine palmitoyltransferase 2                                                                                                        Cpt2              --2.02                0.001
  Carnitine acetyltransferase                                                                                                             Crat              --2.69                0.011
  2,4-dienoyl CoA reductase 1, mitochondrial                                                                                              Decr1             --2.05                0.03
  Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial                                                                               Echs1             --2.39                0.004
  Enoyl-Coenzyme A delta isomerase 2                                                                                                      Eci2              --1.79                0.049
  Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase                                                                      Ehhadh            --3.29                0.034
  Fatty acid binding protein 3, muscle and heart                                                                                          Fabp3             --2.84                0.017
  Glutaryl-Coenzyme A dehydrogenase                                                                                                       Gcdh              --1.97                0.013
  Glycerol-3-phosphate dehydrogenase 2, mitochondrial                                                                                     Gpd2              --2.64                0.028
  Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit   Hadha             --2.23                0.035
  3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase                                                                                       Hmgcl             --1.51                0.03
  Lipase, hormone sensitive                                                                                                               Lipe              --2.14                0.03
  Lipoprotein lipase                                                                                                                      Lpl               --2.31                0.025
  Peroxisomal trans-2-enoyl-CoA reductase                                                                                                 Pecr              --1.67                0.013
  Pyrophosphatase (inorganic) 1                                                                                                           Ppa1              --1.78                0.03
  Protein kinase, AMP-activated, alpha 2 catalytic subunit                                                                                Prkaa2            --2.09                0.034
  Protein kinase, AMP-activated, beta 1 non-catalytic subunit                                                                             Prkab1            --3.96                0.041
  Protein kinase, AMP-activated, beta 2 non-catalytic subunit                                                                             Prkab2            --1.7                 0.041
  Protein kinase, cAMP-dependent, catalytic, alpha                                                                                        Prkaca            --2.03                0.005
  Protein kinase, cAMP dependent, catalytic, beta                                                                                         Prkacb            --1.65                0.031
  Protein kinase, AMP-activated, gamma 1 non-catalytic subunit                                                                            Prkag1            --1.77                0.002
  Solute carrier family 27 (fatty acid transporter), member 1                                                                             Slc27a1           --2.02                0.03
  **MITOCHONDRIAL FUNCTION**                                                                                                                                                      
  Peroxisome proliferator---activated receptor gamma, coactivator 1 alpha                                                                 Ppargc1           --2.14                0.03
  NADH dehydrogenase (ubiquinone) Fe-S protein 7                                                                                          Ndufs7            --2.24                0.015
  Ubiquinol - cytochrome c reductase, complex III subunit VII                                                                             Uqcrq             --1.48                0.05
  COX17 cytochrome c oxidase assembly homolog (*S. cerevisiae*)                                                                           Cox17             --1.68                0.011
  Cytochrome c oxidase subunit IV isoform 1                                                                                               Cox4i1            --1.72                0.02
  Cytochrome c oxidase subunit VIIa polypeptide 2 like                                                                                    Cox7a2l           --1.35                0.049
  Mitofusin 1                                                                                                                             mfn1              --2.41                0.01
  Mitofusin 2                                                                                                                             mfn2              --3.21                0.028
  Clpb caseinolytic peptidase B homolog (*E. coli*) (i.e. HSP78)                                                                          clpb              --2.3                 0.039
  Calcium/calmodulin-dependent protein kinase kinase 2, beta                                                                              Camkk2            --1.77                0.017
  Serine/threonine kinase 11 (i.e. LKB1)                                                                                                  Stk11             --1.86                0.029
  Peroxisome proliferator - activated receptor gamma, coactivator 1 beta                                                                  Ppargc1b          --2.69                0.012
  Tumor protein p53                                                                                                                       Tp53              --2.19                0.025

![**Fold changes in gene expression Old and Old + EXE hearts relative to young hearts (Values are the Means ±S.E.M, *n* = 5 per group). (A)** Genes involved in fatty acid transport and oxidation decline with age and this attenuation is not mitigated with exercise. (CPT1c, Carnitine-palmitoyl transferase 1c; CPT2, Carnitine palmitoyl transferase 2; FATP, Fatty acid transporter; FABP3, Fatty acid binding protein 3; HADHA, Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-CoA hydratase (trifunctional protein); LPL, Lipoprotein lipase). **(B)** AMPK signaling decrements with age involve changes in the gene expression of AMPK subunits and upstream kinases. (AMPKα2, Protein kinase; AMP, activated alpha 2 catalytic subunit; AMPKβ1, Protein kinase; AMP, activated beta 1 non-catalytic subunit; AMPKγ1, Protein kinase; AMP, activated gamma 1 non-catalytic sununit; Camkk2, Calcium/calmodulin-dependent protein kinase kinase 2 beta; LKB1, Liver kinase B 1). **(C)** Mitochondrial biogenesis and maintenance of mitochondrial function decline with age and exercise does not appear to improve the attenuation. (PGC1α, Peroxisome proliferator---activated receptor gamma, coactivator 1 alpha; PGC1β, Peroxisome proliferator---activator receptor gamma, coactivator 1 beta; Mfn1, Mitofusin 1; Mfn2, Mitofusin 2; HSP78, Heat shock protein 78). ^a^*P* \< 0.05 vs. Young, ^b^*P* \< 0.05 vs. Old + EXE.](fphys-07-00352-g0002){#F2}

Effects of exercise training on gene expression in aged hearts
--------------------------------------------------------------

Differences in gene expression were observed between Old and Old + EXE rat hearts (Table [5](#T5){ref-type="table"}). 70 genes associated with glucose metabolism, FA metabolism and mitochondrial function were altered with exercise training in cardiac tissue of old rats compared to that of old sedentary rats. Of these 70 genes, only three were upregulated (*Prkaa1, Slc27a1, Slc27a4*), while 67 genes were downregulated with exercise training and involved genes from the Kreb\'s cycle, glucose transport (Glut4), fatty acid oxidation, and the mitochondrial electron transport chain.

###### 

**Exercise-related changes in gene expression in Old FBN rats**.

  **Gene name**                                                                       **Gene symbol**   **Fold Regulation**   ***p*-value**
  ----------------------------------------------------------------------------------- ----------------- --------------------- ---------------
  **GLUCOSE METABOLISM**                                                                                                      
  Amylo-1,6-glucosidase, 4-alpha-glucanotransferase                                   Agl               --6.15                0.024
  Aldolase A, fructose-bisphosphate                                                   Aldoa             --5.28                0.036
  Enolase 1, (alpha)                                                                  Eno1              --4.1                 0.042
  Enolase 2, gamma, neuronal                                                          Eno2              --3.27                0.019
  Glucose phosphate isomerase                                                         Gpi               --5.59                0.005
  Glycogen synthase kinase 3 alpha                                                    Gsk3a             --3.17                0.046
  Isocitrate dehydrogenase 3 (NAD+) beta                                              Idh3b             --7.7                 0.04
  Isocitrate dehydrogenase 3 (NAD), gamma                                             Idh3g             --5.41                0.027
  Malate dehydrogenase 2, NAD (mitochondrial)                                         Mdh2              --6.31                0.009
  Pyruvate dehydrogenase kinase, isozyme 1                                            Pdk1              --9.29                0.004
  Pyruvate dehydrogenase kinase, isozyme 2                                            Pdk2              --6.48                0.006
  Phosphoglucomutase 3                                                                Pgm3              --1.7                 0.037
  Phosphorylase kinase, gamma 1                                                       Phkg1             --2.78                0.011
  Ribose 5-phosphate isomerase A                                                      Rpia              --2.38                0.018
  Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)                       Sdha              --3.93                0.038
  Succinate-CoA ligase, ADP-forming, beta subunit                                     Sucla2            --5.64                0.021
  Solute carrier family 2 (facilitated glucose transporter), member 4                 Slc2a4            --10.45               0.025
  **FA METABOLISM**                                                                                                           
  Acetyl-Coenzyme A acyltransferase 1A                                                Acaa1a            --9.79                0.001
  Acetyl-Coenzyme A acyltransferase 2                                                 Acaa2             --11.7                0.029
  Acyl-Coenzyme A dehydrogenase family, member 10                                     Acad10            --7.02                0.002
  Acyl-Coenzyme A dehydrogenase family, member 11                                     Acad11            --14.38               0.002
  Acyl-Coenzyme A dehydrogenase family, member 9                                      Acad9             --8.81                0.008
  Acyl-Coenzyme A dehydrogenase, long-chain                                           Acadl             --21.18               0.002
  Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain                           Acadm             --15.17               0.009
  Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain                               Acads             --17.09               0.001
  Acyl-Coenzyme A dehydrogenase, short/branched chain                                 Acadsb            --7.75                0.007
  Acyl-Coenzyme A dehydrogenase, very long chain                                      Acadvl            --9.49                0.002
  Acetyl-coenzyme A acetyltransferase 1                                               Acat1             --14.79               0.004
  Acetyl-Coenzyme A acetyltransferase 3                                               Acat2             --6.25                0.003
  Acyl-CoA thioesterase 2                                                             Acot2             --18.92               \< 0.001
  Acyl-CoA thioesterase 3                                                             Acot3             --3.52                0.024
  Acyl-CoA thioesterase 7                                                             Acot7             --4.43                0.027
  Acyl-CoA thioesterase 8                                                             Acot8             --2.68                0.002
  Acyl-CoA thioesterase 9                                                             Acot9             --5.41                0.001
  Acyl-Coenzyme A oxidase 1, palmitoyl                                                Acox1             --5.16                0.007
  Acyl-Coenzyme A oxidase 3, pristanoyl                                               Acox3             --4.47                0.015
  Acyl-CoA synthetase long-chain family member 1                                      Acsl1             --18.06               \< 0.001
  Acyl-CoA synthetase long-chain family member 3                                      Acsl3             --3.6                 0.008
  Acyl-CoA synthetase long-chain family member 4                                      Acsl4             --2.46                0.011
  Acyl-CoA synthetase long-chain family member 5                                      Acsl5             --2.23                0.001
  Acyl-CoA synthetase long-chain family member 6                                      Acsl6             --5.54                0.01
  3-hydroxybutyrate dehydrogenase, type 1                                             Bdh1              --10.48               0.04
  3-hydroxybutyrate dehydrogenase, type 2                                             Bdh2              --5.03                0.008
  Carnitine palmitoyltransferase 1a, liver                                            Cpt1a             --3.04                0.033
  Carnitine palmitoyltransferase 1b, muscle                                           Cpt1b             --7.93                0.003
  Carnitine palmitoyltransferase 2                                                    Cpt2              --7.02                0.004
  Carnitine acetyltransferase                                                         Crat              --4.27                0.018
  Fatty acid binding protein 3, muscle and heart                                      Fabp3             --7.31                0.034
  Protein kinase, AMP-activated, alpha 1 catalytic subunit                            Prkaa1            1.83                  0.042
  Protein kinase, cAMP-dependent, catalytic, alpha                                    Prkaca            --2.89                0.041
  Protein kinase, cAMP dependent, catalytic, beta                                     Prkacb            --1.43                0.047
  Solute carrier family 27 (fatty acid transporter), member 1                         Slc27a1           1.73                  0.033
  Solute carrier family 27 (fatty acid transporter), member 4                         Slc27a4           3.15                  0.002
  CD36 molecule (thrombospondin receptor)                                             CD36              --2.97                0.001
  Peroxisome proliferator activated receptor alpha                                    Ppara             --9.28                0.029
  **MITOCHONDRIAL FUNCTION**                                                                                                  
  Sirtuin (silent mating type information regulation 2 homolog) 1 (*S. cerevisiae*)   Sirt1             --3.27                0.036
  NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 1                                Ndufa1            --2.24                0.04
  NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14)                          Ndufa6            --4.7                 0.041
  NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 7                                Ndufa7            --5.67                0.033
  NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 8                                Ndufa8            --10.41               0.005
  NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 9                                Ndufa9            --5.71                0.018
  NADH dehyrogenase (ubiquinone) 1, alpha/beta subcomplex, 1                          Ndufab1           --5.67                0.001
  NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 2                                 Ndufb2            --4.49                0.006
  NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 5                                 Ndufb5            --4.72                0.032
  NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 8                                 Ndufb8            --4.92                0.01
  NADH dehyrogenase (ubiquinone) Fe-S protein 6                                       Ndufs6            --2.94                0.047
  Cytochrome c-1                                                                      Cyc1              --5.47                0.033
  Ubiquinol-cytochrome c reductase core protein 2                                     Uqcrc2            --5.38                0.016
  Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1                  Uqcrfs1           --5.11                0.045

Western blot analysis
---------------------

In order to determine if the gene expression changes with age and exercise training were associated with altered protein content, we selected one protein from fatty acid oxidation (PPARα), AMPK signaling (AMPKα~2~), and mitochondrial biogenesis/function (PGC-1α) categories shown in Figure [2](#F2){ref-type="fig"}. Each of these genes had decreased mRNA expression and decreased protein content between Young and Old, although not significantly for PPARα (Figure [3](#F3){ref-type="fig"}). PGC-1α and AMPKα~2~ protein content was decreased in the Old + EXE compared to Young and not different than Old, but PPARα protein content was greater in the Old + EXE rat hearts compared to Old rat hearts.

![**Relative protein content in Young, Old, and Old + EXE groups (*n* = 5 per group)**. Values represent Means ± S.E.M. Old + EXE demonstrate increases in PGC-1α but decreased PPARα and AMPKα~2~ protein content compared to Young and Old, respectively. ^\*^*P* \< 0.05 vs. Young, ^†^*P* \< 0.05 vs. Old + EXE.](fphys-07-00352-g0003){#F3}

Citrate synthase activity
-------------------------

To determine mitochondrial function and volume we assayed citrate synthase activity in left ventricular homogenates. We found that Old rat hearts had increased citrate synthase activity compared to Young hearts, and the Old + EXE hearts demonstrated no differences in citrate synthase activity compared to Young or Old hearts (Figure [4](#F4){ref-type="fig"}).

![**Citrate synthase activity in left ventricular homogenates in young, old, and old exercise-trained hearts (*n* = 5 per group)**. Values indicate Means ± S.E.M. ^\*^*P* \< 0.05.](fphys-07-00352-g0004){#F4}

Discussion {#s4}
==========

To our knowledge this is the first study to determine the effects of age on the expression of a comprehensive group of genes related to cardiac substrate metabolism and mitochondrial function. The other primary aim of this study was to determine whether exercise training in aged rats could alter the age-related gene expression phenotype. We hypothesized that genes associated with fatty acid oxidation, AMPK signaling, and mitochondrial biogenesis/function would be decreased with age and that exercise training would mitigate these changes in aged rat hearts. We found that aging results in the decreased expression of many genes involved with energy metabolism and mitochondrial function but found that exercise training did not improve the downregulation of these genes. In fact, exercise training in aged rats resulted in the downregulation of 67 genes associated with energy metabolism and mitochondrial function compared to aged sedentary rat hearts. Genes associated with glucose metabolism were unaffected by age. The declines in metabolic gene expression were profound, as we observed decreased expression in 42 genes involved with fatty acid metabolism and mitochondrial function in aged hearts compared to young hearts. In aged sedentary hearts altered protein content of PGC-1α and AMPKα~2~ corresponded to declines in gene expression compared to young hearts. We observed that cardiac muscle citrate synthase activity; a common measure of mitochondrial volume in skeletal muscle (Larsen et al., [@B29]) was increased in the aged heart compared to the young heart, while exercise training in aged hearts showed no differences between young and old sedentary rat hearts. Overall, these results suggest a significant change in the expression of genes associated with cardiac metabolic pathways with age that is not improved with exercise training.

We determined that a large number of genes involved with fatty acid metabolism and mitochondrial energy metabolism/biogenesis were downregulated with age, consistent with previous reports suggesting age-related reductions in fatty acid oxidation (Abu-Erreish et al., [@B1]; McMillin et al., [@B32]; Kates et al., [@B25]), AMPK activity (Gonzalez et al., [@B15]; Turdi et al., [@B53]; Zhao et al., [@B59]), and mitochondrial function (Fannin et al., [@B12]; Wanagat et al., [@B56]; Kumaran et al., [@B26]; Bhashyam et al., [@B5]; Preston et al., [@B43]; Jian et al., [@B23]). Specifically, we found genes associated with FAO (i.e., CPT-2, HADHA), AMPK signaling (i.e., AMPKα~2~, CaMKK2, LKB1), and mitochondrial biogenesis (PGC-1α, PGC-1β) with age-related decrements in expression in the myocardium. Cardiac PGC-1α expression has previously been shown to decline with age (Preston et al., [@B43]; Turdi et al., [@B53]), although others have observed no age-related change in cardiac PGC-1α gene expression (LeMoine et al., [@B30]). Our results demonstrated that the genes associated with fatty acid oxidation that were downregulated with age were primarily PPARα regulated transcripts. As in previous studies, we found that expression of FAO genes downstream of PPARα were decreased (Iemitsu et al., [@B22]; LeMoine et al., [@B30]). However, our finding of a decline in PPARα regulated genes associated with FAO in aged hearts occurred despite no change in expression of the PPARα gene itself between young and old hearts. Although, this decline in genes associated with FAO is likely explained by reduced PPARα protein content in old hearts compared to young. This finding suggests that in the aged heart, changes in PPARα is likely to occur downstream of gene expression. Lastly, we demonstrated that the gene expression of AMPKα~2~ decreased with age, which is the major catalytic subunit in the heart and responsible for the phosphorylation of downstream proteins that confer AMPK\'s effect on energy metabolism in the heart (Dolinsky and Dyck, [@B11]). Also, we found decreased gene expression in the aging heart of two protein kinases (CaMKK2 & LKB1) that have been found to phosphorylate AMPK. These findings suggest that declining transcripts of AMPK and two upstream activators (CaMKK2 & LKB1), may play a role in the reduced AMPK activity that has been previously observed in aged hearts (Gonzalez et al., [@B15]; Turdi et al., [@B53]).

There is little information with regard to gene expression and protein content changes in exercise-trained aged rat hearts with regard to fatty acid oxidation, AMPK signaling, or mitochondrial function, but functional studies led us to hypothesize that exercise training would improve the age-related declines in metabolic gene expression. Surprisingly, we found that exercise training did not attenuate the age-related downregulation in the expression of genes involving fatty acid oxidation, AMPK signaling, and mitochondrial function. Specifically, in old exercise-trained hearts compared to old hearts we found a significant decline in the expression of the PPARα gene. PPARα regulated genes that were downregulated by exercise were Acyl CoA dehydrogenases (Acad), CD36, CPT1b, and CPT2. There were no differences in AMPK signaling genes (Figure [2B](#F2){ref-type="fig"}) between Old + EXE and Old rats; however, there was an upregulation of AMPKα~1~ in the exercise trained rats. AMPKα~1~ is ubiquitously expressed in cells and has lower levels of expression in the myocardium compared to AMPKα~2~ (Dolinsky and Dyck, [@B11]). We also found that compared to old rat hearts, exercise trained rat hearts demonstrated further downregulation of many genes involved with glucose transport (Glut4), Kreb\'s cycle and mitochondrial function (complex I and III in the electron transport chain). This downregulation of genes we observed in exercise trained aged hearts will require further work in order to better understand how exercise training induced downregulation of these genes affects cardiac function.

In order to determine if changes in gene expression with age were associated with altered protein content we measured the protein content of PGC-1α, PPARα, and AMPKα~2~. We found that the protein levels of PGC-1α and AMPKα~2~ were decreased in Old hearts compared to Young hearts and PPARα protein content trended toward a significant decline which was similar to the mRNA expression for these genes. In a previous report, mitochondrial oxygen consumption and expression of genes associated with mitogenesis and mitochondrial energy metabolism were both decreased, but mitochondrial number was increased and the mitochondrial marker, citrate synthase was not different in the senescent hearts compared to young (Preston et al., [@B43]). We observed a similar trend, of an increase in citrate synthase activity in Old hearts compared to Young hearts despite a decrease in gene expression of a large number of genes associated with mitochondrial biogenesis.

Western blot analysis determined that in the old-exercise trained rats PGC-1α and AMPKα~2~ protein content decreased compared to young hearts, similar to our findings of decreased gene expression of these two genes. However, we found that PGC-1α mRNA expression was reduced in Old + EXE hearts compared to Old hearts, yet the protein content of PGC-1α was similar. Also, we found that the PPARα mRNA expression was significantly reduced in Old + EXE hearts compared to Young and Old hearts, yet PPARα protein content was significantly greater in Old + EXE hearts compared to Old hearts and similar compared to Young hearts. These results are somewhat conflicted to a report demonstrating that exercise training attenuated the age-related decrement in PPARα mRNA expression and protein content in aged rat myocardium (Iemitsu et al., [@B22]). This study indicated that decreased mRNA expression did result in similar declines in protein content. However, functional changes do not always coincide with coordinate changes in gene expression or protein content (Burelle et al., [@B7]; Zhu et al., [@B60]; Lai et al., [@B27]). Changes in gene expression due to exercise training in aged hearts may or may not coincide with changes in that gene\'s protein product. Specifically, one study demonstrated that exercise training elicited adaptations that lead to an increase in exercise capacity along with augmented glucose and fatty acid oxidation in the myocardium despite no changes in the protein content of several proteins involved with glucose and fatty acid metabolism (Burelle et al., [@B7]). Our results demonstrated despite many genes involved with FAO in the exercise trained aged heart was reduced to aged sedentary hearts, PPARα protein content was greater in exercise trained aged hearts compared to aged sedentary hearts. Future studies looking at the protein content of major proteins involved with β-oxidation and fatty acid transport would enable us to see if exercise training in aged hearts tends to uncouple gene expression from protein content.

Citrate synthase is a common marker of mitochondrial volume used to indicate endurance exercise adaptations in skeletal muscle (Larsen et al., [@B29]). We examined citrate synthase activity in cardiac muscle and found, surprisingly, that aging resulted in an increase in citrate synthase activity and exercise training diminished this effect. Citrate synthase activity was not different in old-exercise trained hearts compared to young or old hearts. This is consistent with previous studies demonstrating that exercise training in rats did not elicit increases in cardiac citrate synthase activity (Oscai et al., [@B40]; Murakami et al., [@B34]; Zonderland et al., [@B61]; Siu et al., [@B50]; Rimbaud et al., [@B44]). We found that exercise training improved functional exercise capacity (Figure [4](#F4){ref-type="fig"}) despite either no changes in gene expression compared to Old hearts or in some cases, a further reduction in the expression of genes associated with energy metabolism and mitochondrial function in the heart. These data suggest that exercise training may impact myocardial energy metabolism and mitochondrial function downstream of gene expression. Also, exercise is known to induce adaptations in skeletal muscle (Hall et al., [@B16]; Bengtsson et al., [@B3]; Betik et al., [@B4]; Kang et al., [@B24]), which may have been responsible for the increased exercise capacity in our old exercise-trained rats.

Limitations {#s5}
===========

One limitation to this study is that we did not determine whether exercise training in young rats leads to a similar downregulation of the expression of these cardiac genes that we found in the exercise trained aged hearts. Cardiac gene expression changes due to exercise training in young rats have been well-studied. These studies showed that mitochondrial or metabolic gene expression in the young rat heart to either increase (Hall et al., [@B16]; Rimbaud et al., [@B44]; Dobrzyn et al., [@B10]; Wadley et al., [@B55]) or not change (Murakami et al., [@B34]; Iemitsu et al., [@B21]; Alessio et al., [@B2]) with exercise training compared to young sedentary rats. Specifically, young hearts respond to exercise training by increasing the expression of genes associated with glucose transport (Hall et al., [@B16]; Rimbaud et al., [@B44]), fatty acid oxidation (Rimbaud et al., [@B44]; Dobrzyn et al., [@B10]), and mitochondrial biogenesis (i.e., PGC-1α and Cox4il; Rinaldi et al., [@B45]; Wadley et al., [@B55]). The results of our study (further decreases in gene expression with exercise training compared to sedentary aging) compared to these previous studies suggest that gene expression changes due to exercise training may be different in the hearts of aged exercise-trained rats compared to young hearts. Future works looking at post-translational modifications and protein activity in genes associated with fatty acid oxidation and mitochondrial function may elucidate molecular mechanisms involved in potential differential exercise training responses between young and old rat hearts.

Another limitation to this study is that our primary endpoint measure was the expression of genes associated with metabolic signaling pathways, substrate energy metabolism and mitochondrial function. Along with our data, previous reports have indicated that changes in tissue mRNA levels are not necessarily predictive of changes in protein levels (Hall et al., [@B16]; Zhu et al., [@B60]; Lai et al., [@B27]). Interestingly, other studies have reported that roughly two-thirds of the variance in protein content may be explained by mRNA concentration (Lu et al., [@B31]; Shankavaram et al., [@B49]). However, due to an increasing appreciation of miRNA interactions, post-translational modifications effecting protein activity, and the unpredictable protein response to stimuli (i.e., exercise training), mRNA is not always a good predictor of protein abundance (Burelle et al., [@B7]; Lu et al., [@B31]; Shankavaram et al., [@B49]). Future studies looking at expression changes in cardiac metabolic and mitochondrial genes, may need to include miRNA expression changes and post-translational protein modifications which will provide a more thorough understanding of metabolic and mitochondrial function in the aged and exercise trained rat heart.

Conclusion {#s6}
==========

This study was the first to utilize a comprehensive approach in the study of age and exercise effects in aged hearts on substrate metabolism and mitochondrial function by an integration of gene expression, protein content, and protein activity. We found that cardiac aging results in the downregulation of a large number of genes associated with fatty acid metabolism, AMPK signaling and mitochondrial function, and exercise in aged-rats did not attenuate these changes and resulted in a further downregulation of expression in many metabolic and mitochondrial genes compared to aged sedentary rat hearts. We also found that gene expression changes may or may not coincide with protein expression. Taken together, our results demonstrated extensive age-related molecular changes in fatty acid metabolism, AMPK signaling and mitochondrial function. These molecular changes are far-reaching and cannot be described by changes in a single gene or a given gene\'s protein product.
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